SCHEMBL20835136

SCHEMBL20835136

C/C=C/CCCCCCCCCCCCCCC(CC/C=C/CCCCCCCCCCCC)NC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.49
PPARD Q03181 4/20 0.49
PPARA Q07869 4/20 0.49
TERT O14746 3/20 0.49
PTPN1 P18031 3/20 0.49
TOP1 P11387 3/20 0.49
HSD17B10 Q99714 3/20 0.49
FABP4 P15090 3/20 0.49
MAPT P10636 2/20 0.49
BLM P54132 2/20 0.49
FAAH O00519 2/20 0.49
LMNA P02545 2/20 0.49
ALOX15 P16050 2/20 0.49
DUSP3 P51452 2/20 0.49
F7 P08709 2/20 0.49
CYP19A1 P11511 2/20 0.49
F3 P13726 2/20 0.49
PTGS1 P23219 2/20 0.49
NR4A2 P43354 2/20 0.49
SIRT6 Q8N6T7 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4758573 0.91 TERT (0.53) PPARGPPARDPPARATERTPTPN1
SCHEMBL4758572 0.91 TERT (0.53) PPARGPPARDPPARATERTPTPN1
SCHEMBL20877099 0.87 ALDH1A1 (0.57) PPARGPPARDPPARAHSD17B10FABP4
SCHEMBL21373201 0.87 ALDH1A1 (0.57) PPARGPPARDPPARAHSD17B10FABP4
SCHEMBL21373200 0.87 ALDH1A1 (0.57) PPARGPPARDPPARAHSD17B10FABP4
SCHEMBL16323618 0.84 FASN (0.54) PPARGFAAHKMT2AALDH1A1KDM4E
SCHEMBL16323325 0.84 FASN (0.54) PPARGFAAHKMT2AALDH1A1KDM4E
SCHEMBL16323616 0.84 FASN (0.54) PPARGFAAHKMT2AALDH1A1KDM4E
SCHEMBL16323324 0.84 FASN (0.54) PPARGFAAHKMT2AALDH1A1KDM4E
SCHEMBL16323872 0.82 FASN (0.53) PPARGFAAHKMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3456317-A1 DI-ALIPHATIC SUBSTITUTED PEGYLATED LIPIDS Alnylam Pharmaceuticals, Inc. (US) 2019-03-20 EP disclosed